HLA-C and cutaneous melanoma: However, in contrast to e.g. cutaneous melanoma, downregulation of MHC class I have shown to correlate to longer survival for patients with uveal melanoma (42, 43, 45), indicating a possibility to introduce non-MHC-restricted treatment strategies.